Timeline
Cizzle Biotechnology
Cizzle Biotechnology gains US accreditation for lung cancer test
Cizzle Biotechnology Holdings shares skyrocketed after US CLIA approval
Cizzle Biotechnology Holdings shares up on US patent grant
More in Medtech & Diagnostics
GENinCode genetic test cuts cardiac risk in Catalonia pilot
A real-world pilot by Catalonia's health service found GENinCode's CARDIO inCode-Score reclassified risk in over 40% of moderate-risk patients and drove measurable improvements in cholesterol and smoking cessation.